https://www.thebodypro.com/category/adverse-events-comorbidities-hiv

Adverse Events, Comorbidities, and HIV

The Latest

open padlock on blue background
News

This Week in HIV Research: Unlocking Secrets of Engagement in Care

Aug. 15, 2019: PCP continuity, ID specialization, and adherence; rules of HIV patient engagement; long-term benefits of financial incentives on adherence; headaches and TDF/FTC.

person rolling joint, focus on hands, cannabis on table
News

This Week in HIV Research: Sex, Drugs, and Broken Bones

Aug. 8, 2019: Casual sex partners increase among U.S. MSM; why some MSM undervalue PrEP; proteinuria prevalence and fracture risk; cannabis, cocaine, and inflammation in people living with HIV.

pregnant stomach
News

This Week in HIV Research: Pregnancy Findings That Aren't About Dolutegravir

Aug. 1, 2019: Raltegravir OK in pregnancy; HIV disclosure and viral suppression among pregnant women; newborn size following HIV exposure; causes of hearing problems among people with HIV.

Steven Deeks, M.D.
Conference Coverage

The State of Cure Research for HIV and Hepatitis B: Similarities and Differences

Steven Deeks, M.D., talks about the medical community's hopes, inspirations, and unanswered questions regarding research for an HIV cure.

pharmacist looking at list
Reference

Hepatitis C (HCV) Initial Treatment Recommendations: A Closer Look at the Options

Although several HCV drugs can cure almost all infections regardless of viral genotype, picking the right drug will depend on each patient's medical history, level of liver damage, and coinfections.

Young nurse handing prescription to senior woman
News

This Week in HIV Research: The Clinical Impacts of Stigma

July 25, 2019: Challenges in viral suppression for young, black women; stigma's impact on women's health; generalized anxiety disorder screening needed; how depression harms the brain.

Ivana Beesham
Conference Coverage

Experts Flummoxed By Conflicting New Data on STIs, HIV, and Long-Term Contraception in Sub-Saharan Africa

ECHO trial results and follow-up studies find unexpectedly low rates of some STIs among users of certain long-term hormonal contraceptives. They also find high HIV rates (unrelated to the contraceptives) that suggest considerable value for PrEP integration.

Syringe.
News

New Drug Approved for Complicated Urinary Tract and Intra-Abdominal Infections

The U.S. Food and Drug Administration has approved a three-drug regimen to treat complicated urinary tract infections and complicated intra-abdominal infections, both of which can be especially problematic for people living with HIV.

couple on the boardwalk surrounded by seagulls
News

This Week in HIV Research: When STIs Flock Together

July 18, 2019: Anal neoplasia risk amidst comorbid HPV and chlamydia; predictive modeling for PrEP outreach; long-term benefits of hepatitis C cure in coinfection; first-line therapy with dolutegravir/lamivudine.

Mexico City's Downtown At Twilight
Conference Coverage

IAS 2019: What to Expect in HIV Science

Six thousand HIV researchers and experts are expected to make their way to Mexico City for the 10th International AIDS Society Conference on HIV Science, which will feature more than 1,000 abstracts highlighting the latest findings in HIV treatment, prevention, and public health policy.